Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progress-free Survival”

10 trials

Showing 10 of 10 results

Not applicableStudy completedNCT01282931
What this trial is testing

Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Health Outcomes Solutions 200
Large-scale testing (Phase 3)Active Not RecruitingNCT05038735
What this trial is testing

Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 212
Post-approval studies (Phase 4)Study completedNCT01143974
What this trial is testing

Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer

Who this might be right for
Locally Advanced Malignant Neoplasm
Chinese Academy of Medical Sciences 28
Large-scale testing (Phase 3)Study completedNCT00970138
What this trial is testing

Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Carcinoma
Fudan University 141
Not applicableStudy completedNCT01291667
What this trial is testing

Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE

Who this might be right for
Progress-free SurvivalOverall Response RateAdverse Events
Shanghai CP Guojian Pharmaceutical Co., Ltd. 330
Large-scale testing (Phase 3)Study completedNCT00929240
What this trial is testing

Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 287
Testing effectiveness (Phase 2)Study completedNCT04393220
What this trial is testing

Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

Who this might be right for
Progress Free Survival (PFS) and Overall Survival (OS)
Fuda Cancer Hospital, Guangzhou 60
Large-scale testing (Phase 3)Study completedNCT00448279
What this trial is testing

THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 58
Large-scale testing (Phase 3)UnknownNCT00764166
What this trial is testing

A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel

Who this might be right for
Adenocarcinoma of the Prostate
Assistance Publique - Hôpitaux de Paris 254
Testing effectiveness (Phase 2)UnknownNCT04905550
What this trial is testing

Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Chongqing University Cancer Hospital 50

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation